These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35027600)

  • 1. Bivalent single domain antibody constructs for effective neutralization of Venezuelan equine encephalitis.
    Liu JL; Zabetakis D; Gardner CL; Burke CW; Glass PJ; Webb EM; Shriver-Lake LC; Anderson GP; Weger-Lucarelli J; Goldman ER
    Sci Rep; 2022 Jan; 12(1):700. PubMed ID: 35027600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Venezuelan equine encephalitis.
    Taylor KG; Paessler S
    Vet Microbiol; 2013 Nov; 167(1-2):145-50. PubMed ID: 23968890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
    Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.
    Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
    Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
    Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus.
    Phillpotts RJ; Jones LD; Howard SC
    Vaccine; 2002 Feb; 20(11-12):1497-504. PubMed ID: 11858855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.
    Kafai NM; Williamson LE; Binshtein E; Sukupolvi-Petty S; Gardner CL; Liu J; Mackin S; Kim AS; Kose N; Carnahan RH; Jung A; Droit L; Reed DS; Handley SA; Klimstra WB; Crowe JE; Diamond MS
    J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35297953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
    Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS
    Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.